Format

Send to

Choose Destination
Clin Rheumatol. 2017 Jan;36(1):155-163. doi: 10.1007/s10067-016-3495-3. Epub 2016 Dec 12.

Depressive symptoms and structural disease progression in knee osteoarthritis: data from the Osteoarthritis Initiative.

Author information

1
Department of Epidemiology and Public Health, University of Maryland School of Medicine, 660 W. Redwood Street, Howard Hall Suite 200, Baltimore, MD, 21201, USA. arathbun@epi.umaryland.edu.
2
Harvard Medical School, Hebrew SeniorLife Institute for Aging Research, Boston, MA, USA.
3
Translational Gerontology Branch, National Institutes on Aging, Bethesda, MD, USA.
4
Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
5
Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Abstract

Depressive symptoms are associated with increases in pain and functional limitations in knee osteoarthritis (OA). The aim was to determine whether depressive symptoms are also associated with greater structural knee OA progression. Four years of annual radiographic and clinical assessments from the Osteoarthritis Initiative were analyzed. The Center for Epidemiological Studies Depression Scale was used to identify depressive symptoms (threshold = ≥16) at the baseline visit. Propensity scores were used to match participants with and without baseline depressive symptoms on multiple potential confounders. Assessment of radiographic knee OA was based on changes in individual radiographic features, which included osteophyte (OST) grade and joint space narrowing (JSN) grade. Mixed effect models were used to examine structural progression between depressed and non-depressed participants with definitive radiographic knee OA. Depressive symptoms were significantly associated with a higher risk of OST progression (odds ratio [OR] = 1.74; 95% confidence interval [CI]: 1.01, 3.00) and a non-significant lower risk of JSN progression (OR = 0.40; 95% CI: 0.14, 1.15) 1 year after baseline. Conversely, there was a non-significant lower risk of OST progression (OR = 0.71; 95% CI: 0.28, 1.79) and higher risk of JSN progression (OR = 1.89; 95% CI: 0.71, 5.06) from year 3 to year 4 of follow-up. However, the patterns of OST progression and JSN progression were not significantly different between the depressed and non-depressed (P = 0.25 and 0.15, respectively). The findings provide no evidence that depressive symptoms have a detectable effect on changes in radiographic disease severity in knee OA.

KEYWORDS:

Bone; Cartilage; Epidemiology; Osteoarthritis

PMID:
27957619
PMCID:
PMC5488696
DOI:
10.1007/s10067-016-3495-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center